[Form 4] Azenta, Inc. Insider Trading Activity

Rhea-AI Filing Summary

Azenta insider sale tied to RSU vesting. Ginger Zhou, SVP and GM, Multiomics, disposed of 1,085 common shares on 08/12/2025 to satisfy withholding tax obligations arising from the vesting of 3,167 restricted stock units that vested on 08/09/2025. The reported sale price was $28.54 per share.

After the transaction the reporting person beneficially owned 26,831 shares. The Form 4 discloses this as a routine tax-withholding disposition rather than an open-market trading decision.

Positive

• Transaction disclosed transparently: Form 4 reports the sale and explains it was to satisfy tax withholding on vested RSUs.
• Continued beneficial ownership: Reporting person retains 26,831 shares after the withholding sale, indicating ongoing equity stake.

Negative

• Disposition of shares: 1,085 shares were sold, which reduces the reporting person's direct holdings.
• Sale executed at $28.54: The sale price of $28.54 establishes the realized proceeds for the withheld portion.

Insights

Corporate Governance Expert

TL;DR: Routine tax-withholding sale tied to RSU vesting; governance signal is neutral.

The disclosure shows an officer sold 1,085 shares solely to satisfy tax withholding on vested RSUs. That practice is common and administratively driven, not an indication of a change in confidence. Continued beneficial ownership of 26,831 shares maintains some alignment with shareholders. Filing appears timely and compliant; the item is immaterial to company-level governance changes.

Securities Analyst

TL;DR: Minor disposition at $28.54 per share; not material to capital structure or valuation.

The transaction removed 1,085 shares from the reporting person's holdings at a reported price of $28.54, resulting from tax withholding on 3,167 vested RSUs. Given the absolute size of the sale and the nature of the transaction, it is unlikely to affect market perception or the issuer's outstanding share count materially. This is a routine insider event rather than a strategic liquidity signal.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Zhou Ginger

(Last) (First) (Middle)

C/O AZENTA, INC.

200 SUMMIT DRIVE, 6TH FLOOR

(Street)

BURLINGTON MA 01803

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Azenta, Inc. [ AZTA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	SVP and GM, Multiomics

3. Date of Earliest Transaction (Month/Day/Year)
08/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common	08/12/2025		D		1,085(1)	D	$28.54	26,831	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sale of shares by the reporting person to satisfy the reporting person's obligations with respect to withholding taxes in connection with the vesting on August 9, 2025 of 3,167 restricted stock units held by the reporting person.

	/s/Ephraim Starr, Attorney-in-fact for Ginger Zhou	08/13/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What transaction did Azenta (AZTA) report on this Form 4?

The Form 4 reports a disposition of 1,085 common shares by Ginger Zhou on 08/12/2025.

Why were the shares sold by the reporting person?

The sale was executed to satisfy withholding tax obligations related to the vesting of 3,167 restricted stock units on 08/09/2025.

At what price were the shares sold?

The reported sale price was $28.54 per share.

How many shares does the reporting person own after the transaction?

After the transaction the reporting person beneficially owned 26,831 shares.

What is the reporting person's role at Azenta?

The reporting person is listed as an officer with the title SVP and GM, Multiomics and is a director.